Safety and Pharmacokinetics of a Single Dose of CCH (3.36 mg) in Subjects With EFP

NCT03675685 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Edematous Fibrosclerotic Panniculopathy

Interventions

BIOLOGICAL: CCH (collagenase clostridium histolyticum)

Sponsor

Endo Pharmaceuticals